PROM1 and central nervous system cancer: As shown in Figure 4, the glioma spheroids treated with Cur-VPDP or PDCP-NP exhibited a dramatically decreased anti-CD133 fluorescence in comparison to the groups treated with PBS or the combinational Cur/DOX solution or even DOX-VPDP (Figure 4(A)), indicating an obvious inhibition of CSCs in these groups.